In vitro activity of the siderophore cephalosporin, cefiderocol, against a recent collection of clinically relevant Gram-negative bacilli from North America and Europe, including carbapenem-nonsusceptible isolates (SIDERO-WT-2014 Study)
Most side effects from both compounds peak during the first 4-8 weeks and then resolve as the body adapts
Metabolic Flexibility GIP and glucagon receptor activation complements GLP-1 appetite suppression with enhanced energy expenditure and improved lipid metabolism signalling
AlphaSense provides this and more
In some embodiments, the lipid-based drug delivery formulation or composition is a lipid emulsion (e.g., microemulsions and oil-in-water emulsions), a lipid vesicle (e.g., liposomes, micelles and transfersomes) or a combination thereof
This can be especially beneficial and useful for animals that will not tolerate having needles placed for long periods of time